If you liked this article you might like

Anavex Plays the Orphan Drug Stock Promotion Game
Catalyst Pharmaceuticals (CPRX) Stock Plunges After FDA 'Refusal to File' Letter
Catalyst Pharma Plummets on FDA 'Refuse-to-File' Letter
Doctors, Patients Battling Sky-High Drug Price Increase